SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 391.16 |
| Enterprise Value ($M) | 803.07 |
| Book Value ($M) | -154.17 |
| Book Value / Share | -2.66 |
| Price / Book | -2.54 |
| NCAV ($M) | -302.59 |
| NCAV / Share | -5.22 |
| Price / NCAV | -1.29 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.48 |
| Return on Assets (ROA) | -0.27 |
| Return on Equity (ROE) | n/a |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 2.96 |
| Current Ratio | 2.96 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 164.92 |
| Assets | 313.33 |
| Liabilities | 467.51 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | 0.00 |
| Net Income | 0.00 |
| Earnings Per Share Basic And Diluted | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 0.00 |
| Cash from Investing | 0.00 |
| Cash from Financing | 0.00 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | Ingalls & Snyder Llc | 7.00 | 7.25 | |
| 13G/A | Demopulos Gregory A MD | 8.80 | 2.74 | |
| 13G | Vanguard Group Inc | 5.04 | 12.36 | |
| 13G | BlackRock, Inc. | 6.80 | 249.15 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 700,749 | 1,726,921 | 40.58 | |
| 298,972 | 1,762,239 | 16.97 | |
| 4,292,923 | 14,038,888 | 30.58 | |
| 53,812 | 396,897 | 13.56 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| NTLA – Intellia Therapeutics, Inc. | OCS – Oculis Holding AG |
| OCUL – Ocular Therapeutix, Inc. | PAHC – Phibro Animal Health Corporation |
| PROC – Procaps Group S.A. |